Erythropoietin (EPO) — EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing
Authors:
- Joerg H. HolsteinJoerg H. Holstein
- Michael D. MengerMMMichael D. Menger
- Claudia ScheuerCSClaudia Scheuer
- Christoph MeierCMChristoph Meier
- Ulf CulemannUCUlf Culemann
- Rainer J. WirbelRWRainer J. Wirbel
- Patric GarciaPGPatric Garcia
- Tim PohlemannTPTim Pohlemann
- 1 February 2007
- journal article
- Published by Elsevier in Life Sciences
- Vol. 80 (10) , 893-900
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds*Critical Care Medicine, 2006
- Vascular Endothelial Growth Factor Gene-Activated Matrix (VEGF165-GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone DefectsJournal of Bone and Mineral Research, 2005
- Erythropoietin crosses the blood–brain barrier to protect against experimental brain injuryProceedings of the National Academy of Sciences, 2000
- Growth Factor Regulation of Fracture RepairJournal of Bone and Mineral Research, 1999
- Does adult fracture repair recapitulate embryonic skeletal formation?Mechanisms of Development, 1999
- VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formationNature Medicine, 1999
- Erythropoietin receptor mRNA expression in human endothelial cells.Proceedings of the National Academy of Sciences, 1994
- Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.Proceedings of the National Academy of Sciences, 1990
- Neutral protein‐degrading enzymes in experimental fracture callus: A preliminary reportJournal of Orthopaedic Research, 1989
- Expression cloning of the murine erythropoietin receptorCell, 1989